CholeS Score for Duration of Elective Laparoscopic Cholecystectomy
Predicts an operating time over 90 minutes for elective laparoscopic cholecystectomy from 10 pre-operative factors (Bharamgoudar 2018; derived in 7,227 CholeS patients, validated in 2,405), to help plan theatre lists.
Score interpretation
In the validation cohort 5.1% of operations with a score of 0–3 lasted over 90 minutes.
→ Standard list planning.
Risk of an operation over 90 minutes lies between the low (5.1%) and high (41.8%) groups; 18–20% of all elective operations took over 90 minutes.
→ Allow extra theatre time when planning the list.
41.8% of operations with a score above 8 lasted over 90 minutes (validation cohort).
→ Plan a longer slot and an appropriately experienced surgeon. The score predicts duration, not conversion or complications.
Interpretation bands for the CholeS Score. Apply clinical judgement and local guidance.
References
- Bharamgoudar R, Sonsale A, Hodson J, Griffiths E; CholeS Study Group, West Midlands Research Collaborative. The development and validation of a scoring tool to predict the operative duration of elective laparoscopic cholecystectomy. Surg Endosc. 2018;32(7):3149–3157.
- NICE CG188. Gallstone disease: diagnosis and management. NICE. 2014.
Related
Curated clinical cross-links plus same-class fallbacks.
- Tranexamic Acid (ICU/Trauma/Surgical) · Antifibrinolytic
- Atracurium Besilate · Non-depolarising Neuromuscular Blocking Agent (Intermediate Duration)
- Protamine Sulphate (Heparin Reversal) · Heparin Reversal / Cardiac Surgery
- Methotrexate (Dermatology — Psoriasis) · Disease-Modifying Antirheumatic / Immunosuppressant
- Potassium Iodide / Lugol's Solution · Thyroid Blocking Agent / Pre-operative Thyroid Preparation
- Acetazolamide (Ménière's Disease) · Carbonic Anhydrase Inhibitor (Diuretic)
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.
